高级检索
当前位置: 首页 > 详情页

Molecular basis of binding between the global post-transcriptional regulator CsrA and the T3SS chaperone CesT.

文献详情

资源类型:
Pubmed体系:

收录情况: ◇ 自然指数

机构: [1]West China Hospital Emergency Department (WCHED), State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University,and Collaborative Innovation Center of Biotherapy, Chengdu, Sichuan 610041, China [2]CAS Key Laboratory of Pathogenic Microbiology and Immunology,Institute of Microbiology, Chinese Academy of Sciences, 100101 Beijing, China [3]Disaster Medicine Center, Sichuan University, Chengdu, 610041 Sichuan,China [4]Savaid Medical School, University of Chinese Academy of Sciences, 100049 Beijing, China [5]National Institute for Viral Disease Control andPrevention, Chinese Center for Disease Control and Prevention (China CDC), 102206 Beijing, China [6]Research Network of Immunity and Health (RNIH),Beijing Institutes of Life Science, Chinese Academy of Sciences, 100101 Beijing, China
出处:

摘要:
The T3SS chaperone CesT is recently shown to interact with the post-transcriptional regulator CsrA to modulate post-attachment signaling in enteropathogenic and enterohemorrhagic Escherichia coli. The molecular basis of the CesT/CsrA binding, however, remains elusive. Here, we show that CesT and CsrA both created two ligand binding sites in their homodimers, forming irregular multimeric complexes in solution. Through construction of a recombinant CsrA-dimer (Re-CsrA) that contains a single CesT binding site, the atomic binding features between CesT and CsrA are delineated via the structure of the CesT/Re-CsrA complex. In contrast to a previously reported N-terminally swapped dimer-form, CesT adopts a dimeric architecture with a swapped C-terminal helix for CsrA engagement. In CsrA, CesT binds to a surface patch that extensively overlaps with its mRNA binding site. The binding mode therefore justifies a mechanism of CsrA-modulation by CesT via competitive inhibition of the CsrA/mRNA interactions.

语种:
PubmedID:
中科院(CAS)分区:
出版当年[2018]版:
大类 | 2 区 综合性期刊
小类 | 2 区 综合性期刊
最新[2023]版:
大类 | 1 区 综合性期刊
小类 | 1 区 综合性期刊
第一作者:
第一作者机构: [1]West China Hospital Emergency Department (WCHED), State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University,and Collaborative Innovation Center of Biotherapy, Chengdu, Sichuan 610041, China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:43390 今日访问量:1 总访问量:3121 更新日期:2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号